Biosimilars
Article
Evernorth chief bullish on driving affordability through biosimilars and access through guided care
Read More
Article
Press Release
Evernorth announces Humira biosimilar available at $0 out of pocket for Accredo patients in June
Read More
Article
Enhancing health outcomes and savings through value-based solutions
Patient engagement paired with cost-containment strategies drives better health outcomes and reduces the financial burden for plan sponsors.
Read More
Article
Express Scripts in 2023: Supporting clients, patients, and health plans
Over the last 12 months, Express Scripts has rolled out numerous groundbreaking programs and projects. Learn about some of the most notable advancements and innovations of 2023.
Read More
Article
Preparing the market for the evolving biosimilar landscape
With more biosimilars and the first major influx of interchangeable inflammatory biosimilars coming to market, proactive education and outreach will be crucial for successful conversions to low-cost o...
Read More